Loading clinical trials...
Loading clinical trials...
Transgender women (TW) have unique challenges related to HIV prevention medication adherence. Left unaddressed, these challenges will prevent TW from accessing the promising long-acting HIV prevention...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Colorado, Denver
Collaborators
NCT07509853 · HIV Prevention, Substance Use, and more
NCT07512869 · HIV Prevention, Substance Use, and more
NCT07292792 · HIV Disease, HIV Prevention
NCT06807580 · Transgender Women
NCT07002866 · HIV Prevention
New York State Psychiatric Institute/Columbia University Medical Center
New York, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions